Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.

Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding

NCT01078324 ·Status: COMPLETED

Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF

NCT01605188 ·Status: COMPLETED

Immune Ablation and Stem Cell Support for Crohn's Disease

NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2

Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

NCT02438410 ·Status: COMPLETED

Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis

NCT02277470 ·Status: UNKNOWN

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

NCT03169894 ·Status: TERMINATED ·Phase: PHASE1

Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis

NCT05680883 ·Status: UNKNOWN

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

NCT00790543 ·Status: COMPLETED

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

NCT00269841 ·Status: COMPLETED ·Phase: PHASE3

Exacerbating Factors in Inflammatory Bowel Disease

NCT01405105 ·Status: COMPLETED

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

NCT01434576 ·Status: WITHDRAWN ·Phase: PHASE1

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

NCT01218360 ·Status: COMPLETED

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

NCT01804166 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT01988961 ·Status: COMPLETED ·Phase: PHASE2

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess

NCT02856763 ·Status: COMPLETED

Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization

NCT03182166 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis

NCT02337608 ·Status: COMPLETED ·Phase: PHASE2

Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

NCT00279435 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Intestinal Biomarker Analysis After ECP for ICI Colitis

NCT06074874 ·Status: COMPLETED

Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)

NCT02463305 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

NCT07080034 ·Status: RECRUITING ·Phase: PHASE2

Prevalence of Lymphoma in IBD

NCT00577538 ·Status: COMPLETED

Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences

NCT05737836 ·Status: NOT_YET_RECRUITING

Identification/Characterization of Changes in Microscopic Colitis

NCT03063957 ·Status: UNKNOWN

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1